SynthesisFrontiers in neurology2024

Efficacy and safety of low-dose rituximab in the treatment of myasthenia gravis: a systemic review and meta-analysis.

Xishuai Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.